Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Humana Stock’s 2026 EPS Guidance Came in Nearly $3 Below Analyst Estimates. Is it a Still Buy Today?
Humana (HUM) stock recently dropped 5% after its Q4 2025 earnings report revealed a 2026 adjusted EPS guidance of at least $9.00, significantly below Wall Street’s $11.92 estimate due to lower Medicare Advantage star ratings. Despite this, membership growth remains strong, with 2026 sales projected to increase by 22.1%. While analysts are divided on the near-term outlook, TIKR’s valuation model projects a potential 267.3% total return by December 2030, suggesting the stock is deeply undervalued for long-term investors.